Onco-Innovations Lists on OTCQB: A Step Towards U.S. Market Expansion

Onco-Innovations Limited (CSE:ONCO) has taken a significant step towards expanding its U.S. market presence by listing its common shares on the OTCQB marketplace under the symbol "ONNVF". This move is expected to enhance the company's visibility and accessibility for U.S. investors, potentially expanding its shareholder base and supporting its long-term growth strategy (Onco-Innovations Limited, 2025).

The OTCQB Venture Market provides an established platform for early-stage and growth companies to enhance their visibility in the U.S. market. Real-time quotes and market information on Onco-Innovations can be found at www.otcmarkets.com, allowing U.S. investors to easily access up-to-date information about the company (Onco-Innovations Limited, 2025).

"This listing marks a significant milestone for Onco-Innovations, allowing us to engage more effectively with U.S. investors and offering us the ability to expand our shareholder base. We are committed to driving innovation in oncology and believe this increased accessibility will support our long-term growth," said Thomas O'Shaughnessy, CEO of the Company (Onco-Innovations Limited, 2025).

While the listing on the OTCQB is a positive development for Onco-Innovations, there are potential risks and challenges associated with the U.S. listing that the company must mitigate to ensure a successful expansion into the U.S. market. These include the failure to expand the shareholder base or attract U.S. investment interest, volatility in the U.S. market, regulatory compliance, increased scrutiny, and the potential for lawsuits related to the heartburn drug Zantac (Onco-Innovations Limited, 2025).

To mitigate these risks, Onco-Innovations can employ several strategies, such as effective communication and investor relations, diversifying funding sources, strengthening the management team, ensuring compliance and reporting, monitoring market conditions, and leveraging the OTCQB platform to increase marketing efforts and engage with U.S.-based analysts and research firms (Onco-Innovations Limited, 2025).



In conclusion, Onco-Innovations' listing on the OTCQB market is a significant step towards increasing its U.S. market presence and expanding its shareholder base. By leveraging the OTCQB platform and implementing strategic initiatives, the company can mitigate potential risks and challenges, ultimately supporting its long-term growth and innovation in the oncology sector.